Isodiol International Inc. Announces Distribution Agreement for South America

Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (FSE:LB6A.F) (the “Company” or “Isodiol”) a global cannabinoid innovator specializing in the development of pharmaceutical and consumer products announces it has signed a distribution partnership with FarmaUSA(TM), a leading global wholesale distributor of imported pharmaceutical products in South America. This is the latest action taken by the Company to further secure its position in the Brazilian market and provide for an additional expansion into greater South America.

Isodiol International Inc. Provides Sponsorship at the US Autism & Asperger Association Conference

Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (FSE:LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces it proudly exhibited at the US Autism & Asperger Association (USAAA) (http://usautism.org/conferences/schedule.html) conference this past weekend in Portland, Oregon and sponsored Dr. Ronald Aung-Din to educate attendees on the potential of treating Autism with Cannabinoids.

Isodiol International Inc. Corporate Update

Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (Frankfurt:LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces unaudited July 2017 revenue numbers of its wholly owned subsidiary ISO International LLC of $1,358,787 USD .

Isodiol International Inc. announces OTC symbol change

Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A) (“Isodiol” or the “Company”) is pleased to announce that the Financial Industry Regulatory Authority, Inc. (“FINRA”) has approved the Company’s OTC voluntary symbol change from “LAGBF” to “ISOLF” to better reflect the Company’s current name.

Isodiol International Inc. Announces Unaudited Quarterly Profit of Iso International LLC

Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (Frankfurt:LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces the operational numbers of its wholly-owned subsidiary for the period from April 1, 2017 to June 30, 2017. Iso International LLC recorded unaudited fiscal Q1 profits of $897,596 based on revenues of $4,919,693 CAD.

Isodiol International Inc. announces unaudited quarterly profit of ISO International LLC

Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces the operational numbers of its wholly-owned subsidiary for the period from April 1, 2017 to June 30, 2017. ISO International LLC recorded unaudited fiscal Q1 profits of $897,596 based on revenues of $4,919,693 CAD.

Canadian Cannabis Investor Magazine Now Available!

ATLANTA, GA / ACCESSWIRE / July 25, 2017 / Canadian CannaInvestor Magazine, the leading industry investment magazine for cannabis investors, analysts, executives, entrepreneurs, and financial media, announced today that it has published its July / August 2017 issue of the Canadian CannaInvestor Magazine. In this issue, we feature: Lexaria Bioscience Corp. (LXX) (LXRP), ABcann Medicinals Inc. (ABCN) (ABCCF), Cannabis Wheaton Income Corp. (CBW), Isodiol International, Inc. (ISOL) (LAGBF), Amercanex, and the Top 25 Cannabis Companies. To subscribe to the Canadian CannaInvestor Magazine, please click on the link https://joom.ag/eApL.

Isodiol International Inc. signs Definitive Licensing Agreement with Canopy Growth Corporation for Canadian and International Distribution

Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED) (https://www.canopygrowth.com).

Isodiol International Inc. announces appointment of Daniel Zuckerman as VP of US Sales

Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has recruited Mr. Daniel Zuckerman to serve as the company’s Vice-President, US Sales.

Isodiol International Inc. Establishes Operations In Mexico And Will Commence Shipment Of Cannabinol Products

VANCOUVER, BC / ACCESSWIRE / June 21, 2017 / Isodiol International Inc. (CSE: ISOL) (OTC PINK: LAGBF) (Frankfurt: LB6A) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has established operations in Mexico and will commence shipment of its Cannabinol products throughout Mexico within the coming weeks.